性别对症状性椎体脆性骨折治疗后疼痛与生活质量演变的影响
该研究基于一项随机临床试验的118/125例患者(男27例/女91例),分析性别对症状性椎体骨折后疼痛与生活质量演变的影响。所有患者接受标准化镇痛和抗骨质疏松治疗,结果显示疼痛与生活质量演变因性别而异,男性更优,女性较差且不依赖于所接受的治疗。
要点
- 症状性椎体脆性骨折后疼痛与生活质量演变因性别而异,男性优于女性。
- 性别差异在2个月后显著,且不依赖于治疗方式。
- 女性疼痛与生活质量演变较差,不依赖于所接受的治疗。
核心结论
- 症状性椎体骨折后疼痛与生活质量演变因性别而异,女性较差且不依赖于所接受的治疗。
研究设计与样本
- 基于先前比较椎体成形术与保守治疗对症状性椎体骨折患者疼痛演变和生活质量影响的随机临床研究,评估118/125例随机患者(男27例/女91例)。
- 所有患者接受标准化镇痛和抗骨质疏松治疗,在基线、2周、2个月和6个月时用VAS和Qualeffo-41评估疼痛和生活质量。
- 按性别比较保守治疗与椎体成形术后的疼痛演变和生活质量,并分析年龄、演变时间、所接受治疗、基线VAS、既往椎体骨折(总数和近期)、 incidental椎体骨折、腰椎和股骨T值、镇痛和抗骨质疏松治疗等因素。
主要发现
- 基线时,年龄(男性74.8 ± 11.2岁 vs. 女性73.2 ± 8.7岁)、演变时间、椎体骨折数量(男性3.8 ± 2.4 vs. 女性3.1 ± 2.4)、所接受治疗(椎体成形术,男性59%,女性45%)、腰椎或股骨T值、基线VAS(男性6.8 ± 2.1 vs. 女性6.8 ± 2.2)或Qualeffo评分(男性52.2 ± 24.4 vs. 女性59.7 ± 20.6)无差异。
- 疼痛和生活质量演变因性别而异,男性更好;这些差异在两个月后显著,不依赖于治疗和随访期间incidental椎体骨折的发生。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: The evolution of pain and quality of life after a symptomatic vertebral fracture differs according to patient gender, with a worse evolution in women independently of the treatment received. PURPOSE: In a previous randomized clinical study comparing the effect of vertebroplasty (VP) vs. conservative therapy (CT) on pain evolution and quality of life (QoL) of patients with symptomatic vertebral fractures (VF), we observed the development of chronic back pain in 23% of subjects, independently of the therapy received. This study analyses the effect of gender on the evolution of pain and QoL in these subjects. METHODS: 118/125 randomized patients (27 males/91 females) with recent symptomatic VFs were evaluated. All received a standardized analgesic and antiosteoporotic format of treatment. Pain and QoL were evaluated by VAS and Qualeffo-41, respectively, at baseline, at 2 weeks and 2 and 6 months. We compared pain evolution and QoL after treatment (CT vs. VP) according to gender, and analysed factors including age, time of evolution, treatment received, baseline VAS, previous VFs (total and recent), incidental VFs, lumbar and femoral T-scores, and analgesic and antiosteoporotic treatment. RESULTS: At baseline, there were no differences in age (males 74.8 ± 11.2 vs. females:73.2 ± 8.7 years), time of evolution, number of VFs (males:3.8 ± 2.4 vs. females: 3.1 ± 2.4), treatment received (VP, males:59%, females:45%), lumbar or femoral T-score, baseline VAS (males:6.8 ± 2.1 vs. females:6.8 ± 2.2) or Qualeffo score (males:52.2 ± 24.4 vs. females:59.7 ± 20.6). Pain and QoL evolution differed according to gender, being better in males. These differences were significant after two months independently of the treatment and the development of incidental VF during follow-up. CONCLUSIONS: Pain and QoL evolution after a symptomatic VF differs according to gender, with a worse evolution in women independently of the treatment received.
引用
- Peris P, Blasco J, Monegal A, et al. Effect of gender on the evolution of pain and quality of life after treatment of symptomatic vertebral fragility fractures. Osteoporos Int. 2023. PMID: 38030857. doi:10.1007/s00198-023-06960-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。